Prioritizing the sourcing and management of preclinical vendors for faster and more successful candidate development.
With more focus, resources and budgets, from pharmaceutical/biotech companies being spent on the preclinical development phase in R&D, sponsor companies are now looking to optimize relationships with the plethora of vendors in this space.
The decision making process in this area is more complex than in the clinical space, and involves a lot more different parties. They are many more decision influencers rather than decision makers. This event will bring the relevant team members to discuss vendor selection, contract development and vendor management, rather than focusing on the scientific aspects of preclinical development.